At the last check on Friday, Gilead Sciences Inc.’s (NASDAQ:GILD) stock was up $0.03, moving up 0.04 percent to $62.51. The average number of shares traded per day over the past five days has been 7,880,788 shares. 3 times new highs have been achieved over the past 5 days, with a $0.63 gain in that time frame. In the last twenty days, the average volume was 8,060,537, while in the previous 50 days, it was 9,475,480.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '22.
Small-cap Uranium stocks are booming in 2022! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here. .
Since last month, GILD stock rose 1.38%. Shares of the company fell to $59.15 on 05/02/22, the lowest level in the past month. A 52-week high of $74.12 was reached on 01/04/22 after having rallying from a 52-week low of $57.19. Since the beginning of this year, GILD’s stock price has dropped by -13.95% or -$10.80, and marked a new high 2 times. However, the stock has declined by -15.67% since its 52-week high.
Gilead Sciences Inc. (GILD) last reported insider trading activity 63 days ago on Mar 11. Pletcher Brett A, the EVP,Corp Affairs & Gen Counsel of the company, disposed of 3,634 shares for $58.24 on Mar 11. It resulted in a $211,644 divestment by the insider. Pletcher Brett A sold 1,691 shares at an average price of $63.89 on Feb 09. The insider now owns 32,576 shares following the transaction. On Feb 01, EVP,Corp Affairs & Gen Counsel Pletcher Brett A sold 14,061 shares at $68.54 apiece. The transaction was valued at $963,682.
Right now, Gilead Sciences Inc. (GILD) has a P/E ratio of about 17.45. The stock’s beta is 0.39. Besides these, the trailing price-to-sales (P/S) ratio of 2.86, the price-to-book (PB) ratio of 3.93, and the price-to-cash flow ratio of 12.43 may also be considered.
The latest dividend of $0.73 per share was paid out, remained unchanged from last year’s $0.73. On Tuesday February 1 2022, a $0.02 dividend increase was announced.
In the three months ended March 30, Gilead Sciences Inc.’s quick ratio stood at 1.30, while its current ratio was 1.50, showing that the company is able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending March 30 was 1.26, and the total debt-to-equity ratio was 1.32. On the profitability front, the trailing twelve-month gross margin is 75.70% percent. In the year ended March 30, operating margins totaled 26.30%. Based on annual data, GILD earned $20.7 billion in gross profit and brought in $27.3 billion in revenue.
A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 16.40%. Return on equity (ROE) for the past 12 months was 22.00%.
In Gilead Sciences Inc.’s quarter-end financial report for March 30, it reported total debt of $25.18 billion against cash and short-term investments of $1.03 billion. According to the earnings report, the company had a lower net income in the recent quarter than it did in the previous quarter. GILD’s revenue rose 2.53% to $7.24 billion during the quarter, while net income inched up to $6.59 billion. While analysts expected Gilead Sciences Inc. to report $1.81 quarterly earnings, the actual figure was $2.12 per share, beating the consensus estimate by 17.10%. During the quarter, the company generated $722.0 million in EBITDA. The liabilities of Gilead Sciences Inc. were 43.16 billion at the end of its most recent quarter ended March 30, and its total debt was $34.61 billion. The value of shareholders’ equity is $1.25 billion.
This quick technical analysis looks at Gilead Sciences Inc.’s (GILD) price momentum. With a historical volatility rate of 26.13%, the RSI 9-day stood at 52.48% on 12 May.
With respect to its five-day moving average, the current Gilead Sciences Inc. price is up by +1.03% percent or $0.63. At present, GILD shares trade -0.02% below its 20-day simple moving average and -14.71% percent below its 100-day simple moving average. However, the stock is currently trading approximately +0.16% above its SMA50 and -11.49% below its SMA200.
Stochastic coefficient K was 63.65% and Stochastic coefficient D was 54.69%, while ATR was 1.38. Given the Stochastic reading of 71.51% for the 14-day period, the RSI (14) reading has been calculated as 52.03%. As of today, the MACD Oscillator reading stands at 0.14, while the 14-day reading stands at 0.34.
Gilead Sciences Inc. downgraded its rating on Gilead Sciences Inc. (NASDAQ: GILD) to a Market perform in a note to investors on February 28, 2022. The analysts firm previously had an Outperform rating on the stock.
With a median target price of $68.00, the current consensus forecast for the stock is $56.00 – $90.00. Based on these forecasts, analysts predict Gilead Sciences Inc. (GILD) will achieve an average price target of $69.75.